Interview with Philippe Ranty, Managing Director, Actavis France
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
Business Solutions is the team of experts at Disneyland Paris, dedicated to organizing large venue events for companies, conferences, and congresses. Disneyland Paris is a unique venue and now the largest all-in-one destination for business tourism in Europe. With its own rail terminal, state-of-the-art congress centers, hotels, restaurants and a huge range of activities on offer, Disneyland Paris offers everything a company may need to make an event an outstanding success! With a staff of 150, Disney Business Solutions has a team of specialists ready to customize any type of event in the various Disneyland Paris venues available for events, including plenary rooms or exhibition areas. With a series of hotels and restaurants nearby, all event attendees are in a close, easily navigable site, also in proximity to the amenities of Disneyland Paris’ two theme parks. The venue is conveniently reached by all modes of transportation including local and regional trains (RER and Eurostar), shuttles from both Charles de Gaulle airport and Orly Airport, as well as a mere 35 minutes drive from Paris.
Contact
+33 160 457 500
Euro Disney Associes S.C.A.
Business Solutions
Boite Postale 112
F-77777 Marne-la-Vallee Cedex 4
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club Inter-pharmaceutique (CIP) is a professional association created in…
As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall?…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always have had the feelings…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as much as possible activities…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
See our Cookie Privacy Policy Here
